Search results for " type 2"

showing 10 items of 761 documents

Issue 1 - “Update on adverse respiratory effects of outdoor air pollution”. Part 1): Outdoor air pollution and respiratory diseases: A general update…

2021

Objective: to summarize the main updated evidence about the health effects of air pollution and to focus on Italian epidemiological experiences on the respiratory effects. Results: The recent literature indicates that there is strong evidence for causal relationships between PM2.5 air pollution exposure and all-cause mortality as well as mortality from acute lower respiratory infections, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lung cancer. A growing body of evidence also suggests causal relationships with type II diabetes and impacts on neonatal mortality from low birth weight and short gestation as well as neurologic effects in both children and adults. …

AdultPulmonary and Respiratory MedicineAir PollutantsSARS-CoV-2Infant NewbornCOVID-19Respiration DisordersDiabetes Mellitus Type 2ItalyAir PollutionHumansParticulate MatterChildAir pollution Air quality guidelines Chronic respiratory diseases Epidemiology Italy Meta-analysis
researchProduct

PCOS: metabolic impact and long-term management.

2012

Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women, affecting up to 10% of those in reproductive age. Furthermore, PCOS presents a lifetime risk of type II diabetes, cardiovascular diseases and endometrial cancer. Women with PCOS have increased cardiovascular risk; however, the risk is not the same in all patients and it is necessary to assess an individual risk profile. There is a discrepancy between increased cardiovascular risk at young age and postmenopausal number of cardiovascular events, probablu depending on changes in androgen ovarian function after the forties. However, changes with age of metabolic profile in women with PCOS have not been studied yet an…

AdultSettore MED/09 - Medicina InternaAdolescentComorbiditySettore MED/11 - Malattie Dell'Apparato CardiovascolareMetforminSettore MED/13 - EndocrinologiaDiabetes Mellitus Type 2Cardiovascular DiseasesRisk FactorsObesity AbdominalPCOS Metabolic Syndrome Cardiovascular risk aging insulin resistance hyperandrogenismHypertensionHumansFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsInsulin ResistanceChildAntihypertensive AgentsDyslipidemiasPolycystic Ovary SyndromeMinerva ginecologica
researchProduct

Serum magnesium and lipids: More clarity is needed

2007

Adultmedicine.medical_specialtyMagnetic Resonance SpectroscopyDiabetes; Lipids; Magnesium; Obesitychemistry.chemical_elementDiabeteInternal medicineDiabetes mellitusHumansMedicineMagnesiumObesityLdl cholesterolbusiness.industryMagnesiumCholesterol HDLDiabetesCholesterol hdlCholesterol LDLLipidmedicine.diseaseLipidsObesityEndocrinologyDiabetes Mellitus Type 2chemistryDiabetes; Lipids; Magnesium; Obesity; Adult; Cholesterol HDL; Cholesterol LDL; Diabetes Mellitus Type 2; Humans; Magnesium; Magnetic Resonance Spectroscopy; Cardiology and Cardiovascular MedicineCardiology and Cardiovascular MedicinebusinessHuman
researchProduct

Maternal-fetal Complications in Pregnancy: A Retrospective Comparison Between Type 1 and Type 2 Diabetes Mellitus

2021

Abstract Background The aim of the study was a retrospective comparison of the differences in maternal-foetal outcomes between women with type 1 and type 2 diabetes mellitus (T1DM and T2DM). Methods A cohort of 135 patients with pregestational diabetes, 73 with T1DM (mean age 29 ± 5 years) and 62 with T2DM (mean age 33 ± 6 years), in intensive insulin treatment throughout pregnancy were evaluated. Clinical and metabolic parameters and the prevalence of maternal and foetal complications were assessed. Results Women with T1DM showed lower pregestational BMI (p < 0.001), pregestational weight (p < 0.001), weight at delivery (p < 0.001), ∆_total_insulin requirement (IR) at the first, s…

Adultmedicine.medical_specialtyMultivariate analysisendocrine system diseasesmedicine.medical_treatmentReproductive medicine030209 endocrinology & metabolismAbortionMacrosomialcsh:Gynecology and obstetricsBody Mass IndexFetal Macrosomia03 medical and health sciencesYoung Adult0302 clinical medicinePregnancyRisk FactorsInsulin requirementmedicinePrevalenceHumansInsulinlcsh:RG1-991Retrospective StudiesGlycated HemoglobinPregnancy030219 obstetrics & reproductive medicineObstetricsbusiness.industryInsulinAbortionObstetrics and GynecologyType 2 Diabetes Mellitusnutritional and metabolic diseasesmedicine.diseaseGestational Weight GainAbortion SpontaneousDiabetes Mellitus Type 1Diabetes Mellitus Type 2Large for gestational ageCohortFemalePregnancy Trimestersmedicine.symptomInsulin ResistancebusinessWeight gainResearch Article
researchProduct

Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients

2015

Abstract Objective We aim to assess the effect of metformin treatment on metabolic parameters, endothelial function and inflammatory markers in polycystic ovary syndrome (PCOS) subjects. Methods The study population consisted of 40 reproductive-age women with PCOS, who underwent treatment with metformin during a 12-week period, and their corresponding matched controls (n = 44). We evaluated endocrinological parameters, adhesion molecules (vascular cell adhesion molecule 1 (VCAM-1), intercellular cell adhesion molecule 1 (ICAM-1) and E-selectin) and proinflammatory cytokines (interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα)) in serum. In addition, interactions between human umbili…

Adultmedicine.medical_specialtyTime FactorsAdolescentendocrine system diseasesEndotheliumType 2 diabetesProinflammatory cytokineYoung AdultInsulin resistanceInternal medicineCell AdhesionHuman Umbilical Vein Endothelial CellsLeukocytesmedicineHumansLeukocyte RollingEndothelium Leukocyte Metformin Mitochondria PCOS Type 2 diabetesCells CulturedCell adhesion moleculebusiness.industryEndothelial Cellsnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryCoculture TechniquesMetforminMetforminEndothelial stem cellTreatment Outcomemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2SpainCytokinesFemaleInflammation MediatorsCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesBiomarkersPolycystic Ovary Syndromemedicine.drugAtherosclerosis
researchProduct

Expression and distribution of key enzymes of the cyclic GMP signaling in the human clitoris: relation to phosphodiesterase type 5 (PDE5)

2011

The clitoris contributes to the normal female sexual response cycle. A significance of cyclic guanosine monophosphate (GMP) has been assumed in the control of clitoral vascular smooth muscle. As only a few investigations on the physiology of the vascular and non-vascular clitoral tissue have been carried out, knowledge on the mechanisms controlling this particular female genital organ is still vague. It has been suggested that human clitoral corpus cavernosum smooth muscle is regulated by nitric oxide (NO)/cyclic GMP and related key enzymes, such as NO synthases (NOSs) and the phosphodiesterase type 5 (PDE5). The present study evaluated in the human clitoris, by means of immunohistochemistr…

Adultmedicine.medical_specialtyVascular smooth muscleStromal cellAdolescentNitric Oxide Synthase Type IIIUrologyClitorisBiologyEndothelial NOSSecond Messenger SystemsClitorisNitric oxideYoung Adultchemistry.chemical_compoundInternal medicineCyclic GMP-Dependent Protein KinasesmedicineHumansVimentinProtein kinase ACyclic GMPCyclic guanosine monophosphateCyclic Nucleotide Phosphodiesterases Type 5Cyclic Nucleotide Phosphodiesterases Type 2Immunohistochemistrymedicine.anatomical_structureEndocrinologychemistrycGMP-specific phosphodiesterase type 5FemaleInternational Journal of Impotence Research
researchProduct

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents

2021

Abstract Aims To analyze therapeutic inertia in type 2 diabetes (T2D) subjects with suboptimal glycemic control and treated with ≥2 non-insulin antidiabetic agents in a primary care setting. Methods A retrospective study was conducted using electronic medical records from subjects with HbA1c ≥7.0% (≥53 mmol/mol). Therapeutic inertia was defined as the absence of treatment intensification despite suboptimal glycemic control where intensification should have been implemented (HbA1c ≥7.5% [≥58 mmol/mol]). Time to the first intensification with non-insulin antidiabetic agent or insulin and HbA1c values at the time of intensification were evaluated by competing risk analysis. Results 2652 adults…

Adultmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTreatment intensificationInsulins030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsRetrospective StudiesTherapeutic inertiaGlycemicGlycated Hemoglobinbusiness.industryMedical recordInsulinnutritional and metabolic diseasesRetrospective cohort studymedicine.diseaseDiabetes Mellitus Type 2businessJournal of Diabetes and its Complications
researchProduct

Comparison of the effect of ginger and aloe vera mouthwashes on xerostomia in patients with type 2 diabetes: A clinical trial, triple-blind

2021

Background Ginger and aloe vera are two medicinal herbs mostly used to produce mouthwash. This study aimed to compare the effects of ginger and aloe vera mouthwashes on the xerostomia in patients referred to Bandar Abbas diabetes clinic (Iran). Material and Methods In this triple-blind clinical trial, three groups (n=35 patients in each group) were studied. One group was given aloe vera mouthwash, the other group used ginger mouthwash, and the control group was only given normal saline. All the mouthwashes were used 20 ccs three times daily for 14 consecutive days. The symptoms and severity of xerostomia were measured before and after the intervention by the questionnaire proposed by Fox et…

Adultmedicine.medical_specialtymedicine.medical_treatmentMouthwashesType 2 diabetesGingerIranXerostomiaAloe veralaw.inventionMcNemar's testbone regenerationstomatognathic systemRandomized controlled triallawInternal medicineDiabetes mellitusHumansMedicineIn patientthird molarxenograftAloeGeneral DentistrySalineUNESCO:CIENCIAS MÉDICASAgedtooth extractionOral Medicine and Pathologybiologybusiness.industryResearchMiddle Agedbiology.organism_classificationmedicine.diseaseClinical trialDiabetes Mellitus Type 2OtorhinolaryngologySurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Contraception in diabetic women: an Italian study

2005

Abstract Over 1 year, a survey on contraception and obstetric history was performed on a cohort of 667 Caucasian fertile diabetic women (446, type 1 and 201, type 2) living in Italy. Results: Of these women, 30.4% used hormonal contraceptives, 12.0% intra-uterine device (IUD), 10.7% declared they used no contraception, 47.0% only utilised barrier and/or natural methods. However, irrespective of their previous contraceptive strategy, 7.2% of all the studied population was surgically sterilized during caesarean section. Hormonal contraception: Of these women, 60.4% was prescribed by a gynaecologist, 11.2% by a diabetologist, 15% by both of them and 13.4% by others. The proportion using oral c…

Adultmedicine.medical_specialtytype 1 diabetesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPopulationdiabetic pregnancycontraception; diabetic pregnancy; type 1 diabetes; type 2 diabetesWhite PeopleCohort StudiesEndocrinologyInternal MedicinemedicineHumansCaesarean sectioneducationGynecologyPregnancyeducation.field_of_studyDiabetic RetinopathyGeographyMarital Statusbusiness.industryObstetricsSmokingGeneral Medicinemedicine.diseaseDiabetes Mellitus Type 1Diabetes Mellitus Type 2ItalycontraceptionHormonal contraceptionFamily planningCohortFemaletype 2 diabetesbusinessDeveloped countryCohort studyDiabetes Research and Clinical Practice
researchProduct

Éducation thérapeutique structurée par les pairs éducateurs dans le diabète de type 2 au Mali

2016

International audience; Les pays en développement sont confrontés à des ressources financières et humaines limitées, malgré les besoins importants et les défis de santé multiples. Plus de 75% des personnes atteintes de diabète dans le monde vivent dans des pays en développement. En Afrique, le nombre de personnes atteintes de diabète devrait doubler dans les 30 prochaines années.Les défis à relever pour offrir une éducation visant à permettre aux personnes souffrant d'une condition chronique de la gérer eux-mêmes se situent à trois niveaux : les patients, les prestataires de soins, et les systèmes de santé.Au Mali, après le développement de capacités de prise en charge des patients diabétiq…

Afrique[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieMalade[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieDiabète non insulinodépendantMaliPays en développementDiabete de type 2Education patient
researchProduct